A detailed history of Graney & King, LLC transactions in Organon & Co. stock. As of the latest transaction made, Graney & King, LLC holds 15 shares of OGN stock, worth $224. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Holding current value
$224
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$14.44 - $18.83 $216 - $282
15 New
15 $224,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.8B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Graney & King, LLC Portfolio

Follow Graney & King, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graney & King, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graney & King, LLC with notifications on news.